Models based on alpha-synuclein, LRRK2 or 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)/MPP+ appear substantially different at first glance and all these models only partially reproduce the pathophysiology of human PD. This evidence concerns the gene LRRK2 and Parkinson disease.